News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AEterna Zentaris (AEZS) Reports Fourth Quarter and Full-Year 2012 Financial and Operating Results


3/22/2013 6:19:38 AM

QUEBEC CITY, March 21, 2013 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (AEZ.TO) (the "Company"), a late-stage drug development company specializing in oncology and endocrinology, today reported financial and operating results as at and for the fourth quarter and the year ended December 31, 2012 .

Read at Yahoo Finance

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES